SSR504734 is an Orally Active, Selective and Reversible GlyT1 Inhibitor

Glycine transporters (GlyTs) are the Na+/Cl--dependent plasmalemmal neurotransmitter transporters. GlyTs comprise GlyT1 and GlyT2. They serve to terminate the signaling of glycine by mediating its reuptake from the synaptic cleft…